StockData
Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc. (STOK) KPIs and segments

STOKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30179% above fair value
$26.68+0.48 (+1.83%)

Close on Nov 13, 2026Market cap $1.72BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Stoke Therapeutics's business

Coming soon

This tab will track the numbers specific to Stoke Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?